ClinVar Miner

Submissions for variant NM_000455.5(STK11):c.1012G>A (p.Val338Met)

gnomAD frequency: 0.00001  dbSNP: rs587782302
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 14
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000131186 SCV000186135 likely benign Hereditary cancer-predisposing syndrome 2022-01-04 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Invitae RCV000168376 SCV000219067 uncertain significance Peutz-Jeghers syndrome 2024-01-22 criteria provided, single submitter clinical testing This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 338 of the STK11 protein (p.Val338Met). This variant is present in population databases (rs587782302, gnomAD 0.02%). This missense change has been observed in individual(s) with colorectal cancer (PMID: 28135145). ClinVar contains an entry for this variant (Variation ID: 142198). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt STK11 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
GeneDx RCV000222337 SCV000279260 likely benign not provided 2019-08-19 criteria provided, single submitter clinical testing Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 28135145)
Counsyl RCV000168376 SCV000489083 uncertain significance Peutz-Jeghers syndrome 2016-08-15 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV000131186 SCV000686573 uncertain significance Hereditary cancer-predisposing syndrome 2023-01-25 criteria provided, single submitter clinical testing This missense variant replaces valine with methionine at codon 338 of the STK11 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with colorectal cancer (PMID: 28135145). This variant has been identified in 5/238888 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000222337 SCV000888633 uncertain significance not provided 2017-09-19 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV000765433 SCV000896717 uncertain significance Carcinoma of pancreas; Peutz-Jeghers syndrome; Malignant tumor of testis 2018-10-31 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV000168376 SCV002057304 uncertain significance Peutz-Jeghers syndrome 2021-07-15 criteria provided, single submitter clinical testing
Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein RCV002243796 SCV002512235 uncertain significance Familial adenomatous polyposis 2 2021-09-26 criteria provided, single submitter clinical testing ACMG classification criteria: PM2 moderate, BP4 supporting
Sema4, Sema4 RCV000131186 SCV002531617 uncertain significance Hereditary cancer-predisposing syndrome 2022-01-19 criteria provided, single submitter curation
Myriad Genetics, Inc. RCV000168376 SCV004017986 uncertain significance Peutz-Jeghers syndrome 2023-04-14 criteria provided, single submitter clinical testing This variant is classified as a variant of uncertain significance as there is insufficient evidence to determine its impact on protein function and/or cancer risk.
PreventionGenetics, part of Exact Sciences RCV003407552 SCV004116326 uncertain significance STK11-related disorder 2023-05-25 criteria provided, single submitter clinical testing The STK11 c.1012G>A variant is predicted to result in the amino acid substitution p.Val338Met. This variant has been reported in an individual with colorectal cancer (Table A4, Yurgelun et al. 2017. PubMed ID: 28135145). This variant is reported in 0.020% of alleles in individuals of Ashkenazi Jewish descent in gnomAD (http://gnomad.broadinstitute.org/variant/19-1223075-G-A). It has conflicting interpretations of likely benign and uncertain significance in ClinVar (https://preview.ncbi.nlm.nih.gov/clinvar/variation/142198/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.
All of Us Research Program, National Institutes of Health RCV000168376 SCV004818955 uncertain significance Peutz-Jeghers syndrome 2023-12-11 criteria provided, single submitter clinical testing This missense variant replaces valine with methionine at codon 338 of the STK11 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with colorectal cancer (PMID: 28135145). This variant has been identified in 5/238888 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
Department of Pathology and Laboratory Medicine, Sinai Health System RCV001354464 SCV001549089 uncertain significance Generalized juvenile polyposis/juvenile polyposis coli no assertion criteria provided clinical testing The STK11 p.Val338Met variant was identified in 1 of 2116 proband chromosomes (frequency: 0.0005) from individuals or families with colorectal cancer (Yurgelun 2017). The variant was also identified in dbSNP (ID: rs587782302) as "With Uncertain significance allele", ClinVar (classified as uncertain significance by Invitae, Ambry Genetics, GeneDx, Counsyl and Color). The variant was not identified in LOVD 3.0, database. The variant was identified in control databases in 4 of 236508 chromosomes at a frequency of 0.00002 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: European in 2 of 107242 chromosomes (freq: 0.00002), Ashkenazi Jewish in 2 of 9626 chromosomes (freq: 0.0002), while the variant was not observed in the African, Other, Latino, East Asian, Finnish, or South Asian populations. The p.Val338 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.